Finance

Lists
300039:SHE
Shanghai Kaibao Pharmaceutical Co Ltd
CNÂ¥5.07
-2.87%
(-0.15) 1D
Sep 11, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300039...
Open
CNÂ¥5.18
High
CNÂ¥5.20
Low
CNÂ¥5.04
Mkt. cap
5.30B
Avg. vol.
53.39M
Volume
16.54M
Dividend
2.56%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 29, 2026
P/E ratio
20.51
52-wk high
CNÂ¥6.77
52-wk low
CNÂ¥4.02
EPS
CNÂ¥0.25
Shares outstanding
1.05B
No. of employees
1K
Open
CNÂ¥5.18
High
CNÂ¥5.20
Low
CNÂ¥5.04
Mkt. cap
5.30B
Avg. vol.
53.39M
Volume
16.54M
Dividend
2.56%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 29, 2026
P/E ratio
20.51
52-wk high
CNÂ¥6.77
52-wk low
CNÂ¥4.02
EPS
CNÂ¥0.25
Shares outstanding
1.05B
No. of employees
1K
About Shanghai Kaibao Pharmaceutical Co Ltd
CEO-
Employees1.2K
FoundedApr 12, 2000
Headquarters-
SectorPharmaceutical industry
Websitexykb.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
214.37M
333.63M
283.25M
179.67M
Cost of goods sold
43.67M
64.49M
54.33M
37.48M
Cost of revenue
43.67M
64.49M
54.33M
37.48M
Research and development expenses
8.86M
25.01M
19.42M
20.50M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
106.04M
148.00M
137.79M
88.60M
Operating expense
114.94M
185.39M
159.80M
109.86M
Total operating expenses
158.60M
249.87M
214.13M
147.34M
Operating income
55.77M
83.76M
69.12M
32.34M
Other non operating income
-23.48K
-14.50K
-15.08K
19.37M
EBT including unusual items
75.82M
101.69M
77.06M
44.44M
EBT excluding unusual items
74.92M
104.13M
77.58M
47.95M
Income tax expense
10.85M
10.35M
12.31M
7.46M
Effective tax rate
14.31%
10.18%
15.97%
16.79%
Other operating expenses
202.62K
8.82M
4.21M
-857.11K
Net income
65.09M
91.54M
64.87M
37.07M
Net profit margin
30.36%
27.44%
22.90%
20.63%
Earnings per share
-
-
-
-
Interest and investment income
19.21M
20.41M
8.51M
39.73K
Interest expense
-32.96K
-21.18K
-39.73K
-3.80M
Net interest expenses
19.17M
20.39M
8.47M
-3.76M
Depreciation and amortization charges
-
-
-
-
EBITDA
64.62M
92.13M
77.49M
41.39M
Gain or loss from assets sale
187.25K
-39.32K
-
57.03K
AI content may include mistakes. Learn more
Google apps